Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Miguel Angel Cajigal Vera"'
Tras el éxito de Otra historia del arte, vuelve El Barroquista con un libro imprescindible que nos invita a reflexionar sobre por qué la arquitectura es el mejor antídoto contra el olvido histórico. ¿Sabes por qué en tu casa vives mejor que Cat
La Historia del Arte con uno de los grandes divulgadores de España: @ElBarroquista. Cualquiera que haya visitado un museo o haya hojeado un libro sobre arte habrá escuchado o leído frases rimbombantes y categóricas como «Nos encontramos ante la
Autor:
M Miguelez, M Suárez, E Gomez, J Merino, M Navarro, G Calzado, T Betancor, E Ramos, P. Diaz, A Ferrer, Miguel Angel Cajigal Vera
Publikováno v:
Eur J Hosp Pharm
Background Emtricitabine/elvitegravir/cobicistat/tenofovir (FTC/EVG/COBI/TAF) changes levels of cholesterol and triglyceride. Purpose To assess the effect on lipid metabolism and renal function in patients with human immunodeficiency virus (HIV) trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a21873770bcad309430ba8915f47c12
https://europepmc.org/articles/PMC7535317/
https://europepmc.org/articles/PMC7535317/
Autor:
E Gomez, E Ramos, M Navarro, I Plasencia, A Ferrer, G Calzado, T Betancor, M Suárez, Miguel Angel Cajigal Vera, P. Diaz, J Merino
Publikováno v:
Eur J Hosp Pharm
Background The use of inhaled colistimethate in our population guaranteed a good antibacterial coverage in our patients. Purpose To analyse the use of inhaled colistimethate according to indication and prescribed dose, presence or absence of the infe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d884df342c7a2963dd41c7aafd1770
https://doi.org/10.1136/ejhpharm-2018-eahpconf.147
https://doi.org/10.1136/ejhpharm-2018-eahpconf.147
Autor:
E Ramos, M Suárez, Miguel Angel Cajigal Vera, J Merino, T Betancor, M Navarro, I Plasencia, G Calzado, A Ferrer, P. Diaz
Publikováno v:
Eur J Hosp Pharm
Background Fingolimod changes lymphocyte count. Purpose To evaluate changes in lymphocyte count and infection incidence in patients with multiple sclerosis (MS) receiving fingolimod. Material and methods Retrospective study that included all fingolim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7e5010e0ffc7fc35ff3ffa019354b5a
https://doi.org/10.1136/ejhpharm-2018-eahpconf.429
https://doi.org/10.1136/ejhpharm-2018-eahpconf.429
Autor:
J Merino, E Gomez, T Betancor, Miguel Angel Cajigal Vera, I Plasencia, G Calzado, A Ferrer, E Tevar, E Ramos, M Navarro, M Suárez
Publikováno v:
Eur J Hosp Pharm
Background We ask if dalvabancina and tedizolid are good alternatives for strains with reduced sensitivity to vancomycin, daptomycin or linezolid. Purpose To determine the most cost-effective treatment option for GRAM +microorganisms with reduced sen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd2597761123526e165efb978178326
https://doi.org/10.1136/ejhpharm-2018-eahpconf.148
https://doi.org/10.1136/ejhpharm-2018-eahpconf.148